Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Nasal drug delivery is still primarily associated with locally-effective drugs, but next-generation products utilising the benefits of nasal administration-such as easy access to a relatively permeable mucosa, the presence of immunocompetent cells, and a direct route to the brain-are under investiga...
Saved in:
Main Authors: | Marie Trenkel (Author), Regina Scherließ (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Trenkel, M.; Scherließ, R. Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects. <i>Pharmaceutics</i> 2021, <i>13</i>, 385
by: Marie Trenkel, et al.
Published: (2023) -
Intranasal Vaccine Formulation: Advancing Towards Nasal Dry Powder Formulation
by: Kelvin Opoku Forkuoh, et al.
Published: (2023) -
Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
by: Gieszinger P, et al.
Published: (2017) -
Visualization of nasal powder distribution using biomimetic human nasal cavity model
by: Jiawen Su, et al.
Published: (2024) -
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
by: Péter Gieszinger, et al.
Published: (2021)